Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2015First federal award
$4.1MFederal grants as PI5 awards
3Patents grantedLatest Sep 22, 2026
13Papers137 citations
Federal awards and patents by year
AwardsPatents
5 awards · $4.1M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| May 27, 2020 | NIH | SBIR Phase II IND-enabling assay validation and toxicology studies on AKS-107: a novel antigen-specific B cell therapeutic to prevent Type 1 Diabetes | $924K | Akston Biosciences Corp |
| Jun 25, 2019 | NIH | SBIR Phase II IND-enabling assay validation and toxicology studies on AKS-107: a novel antigen-specific B cell therapeutic to prevent Type 1 Diabetes | $979K | Akston Biosciences Corp |
| Feb 16, 2018 | NIH | SBIR Phase II Selective Depletion of Insulin-Specific B cells to Prevent Type 1 Diabetes | $999K | Akston Biosciences Corp |
| Feb 8, 2017 | NIH | SBIR Phase II Selective Depletion of Insulin-Specific B cells to Prevent Type 1 Diabetes | $998K | Akston Biosciences Corp |
| Sep 10, 2015 | NIH | SBIR Phase I Selective Removal of Insulin-Specific B-cells to Prevent Type I Diabetes in NOD Mice | $250K | Akston Biosciences Corp |
4 patents as inventor
- US 12454565Akston Biosciences CorpOct 28, 2025
- US 12686709Akston Biosciences CorpJul 21, 2026
- US 12742000Akston Biosciences CorpSep 22, 2026
- US Akston Biosciences Corp—
Matched by the first inventor’s name and the patent’s company.
Peer ranks
Federal funding#369
Awards as PI#417
Patents#63
Companies
- Akston Biosciences CorpLinked by awards · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.